Replies to post #115749 on Amarin Corp Plc (AMRN)

[sts66]

the ITC win would triple the pps easily because of the potential expansion in sales

Doubtful - anyone who wants high purity EPA but isn't taking V is likely because insurance doesn't cover it - I don't think getting off-label scrips is a serious nationwide problem unless you have Kaiser - I could see the pps going up 20% or so on the news, dunno if would stay there though - won't really have an affect on V sales until R-IT is done and gains FDA approval, then there's no reason to take DS EPA, all insurance will cover it - especially true if TGs are shown to be an artifact, not a direct cause of CVD.